Abstract
Low-molecular-weight heparins (LMWHs) and heparinoids are anticoagulants that may be associated with lower risks of hemorrhage and more powerful antithrombotic effects than standard unfractionated heparin (UFH). The objective of this review was to compare the effects of LMWHs or heparinoids with those of UFH in people with acute, confirmed, or presumed ischemic stroke. We searched the Cochrane Stroke Group trials register (last searched November 2003). In addition, we searched the Cochrane Central Register of Controlled Trials (The Cochrane Library 2003, Issue 4), MEDLINE (1966 to October 2003), and EMBASE (1980 to October 2003). Randomized trials comparing heparinoids or LMWHs with standard UFH in …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
